12:00 AM
Apr 05, 2010
 |  BC Week In Review  |  Company News  |  Deals

Pfenex, Ranbaxy deal

Ranbaxy will develop an undisclosed biosimilar produced using Pfenex Expression Technology, a Pseudomonas fluorescens-based recombinant protein expression...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >